Novo Nordisk on Saturday said its diabetes pill Rybelsus showed cardiovascular benefits in a late-stage trial, paving the way for it to become a new treatment option for people living with diabetes and heart disease. The pill lowered the risk of cardiovascular-related death, heart attack and stroke by 14% compared to...
Category: News
Dollar Tree says it’s winning over higher-income shoppers and may offset tariffs with price hikes
Erin Scott | ReutersDollar Tree said Wednesday that it's gaining market share with higher-income consumers and could raise prices on some products to offset President Donald Trump's tariffs.The discount retailer's CEO, Michael Creedon, said the company is seeing "value-seeking behavior across all income groups." While Dollar Tree has always relied...
Eli Lilly will soon release key data on its weight loss pill. Here’s why it could be a game-changer
A sign with the company logo sits outside of the headquarters of Eli Lilly in Indianapolis, Indiana, on March 17, 2024.Scott Olson | Getty ImagesPatients, doctors and investors will soon learn a lot more about a new, more convenient treatment that could shake up the booming weight loss drug market.Eli Lilly...
Zepbound copycats remain online despite FDA ban
This week was supposed to mark the end of compounding pharmacies making copycat versions of Eli Lilly's weight-loss drug Zepbound and its diabetes drug Mounjaro. Online, it doesn't look like much has changed. Popular websites like Amble, EllieMD, Willow and Mochi Health are all still advertising versions of tirzepatide, the active...
NBA may bring back iconic highlight show ‘NBA Inside Stuff’
Ahmad Rashad and Willow Bay look on during an Inside Stuff Episode taping circa 1993 in Secaucus, New Jersey.Nathaniel S. Butler | National Basketball Association | Getty ImagesThe NBA is quietly preparing to bring back its iconic show "NBA Inside Stuff."On Monday, the league filed two trademark applications for "NBA...